End Stage Liver Disease

"End Stage Liver Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.

Descriptor ID	D058625
MeSH Number(s)	C06.552.308.500.177
Concept/Terms	End Stage Liver Disease End Stage Liver Disease Chronic Liver Failure Chronic Liver Failure Chronic Liver Failures Failure, Chronic Liver Failures, Chronic Liver Liver Failures, Chronic Liver Failure, Chronic

Below are MeSH descriptors whose meaning is more general than "End Stage Liver Disease".

Diseases [C]
Digestive System Diseases [C06]
Liver Diseases [C06.552]
Hepatic Insufficiency [C06.552.308]
Liver Failure [C06.552.308.500]
End Stage Liver Disease [C06.552.308.500.177]

Below are MeSH descriptors whose meaning is related to "End Stage Liver Disease".

Below are MeSH descriptors whose meaning is more specific than "End Stage Liver Disease".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "End Stage Liver Disease" by people in this website by year, and whether "End Stage Liver Disease" was a major or minor topic of these publications.

Bar chart showing 22 publications over 8 distinct years, with a maximum of 4 publications in 2019 and 2021 and 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2014	1	0	1
2016	0	2	2
2019	4	0	4
2020	3	0	3
2021	4	0	4
2022	2	0	2
2023	3	1	4
2024	0	2	2

Below are the most recent publications written about "End Stage Liver Disease" by people in Profiles.

Bittermann T, Byhoff E. CON: Satellite clinics are a marketing tool and do not improve access and equity in liver transplantation. Liver Transpl. 2024 Oct 01; 30(10):1082-1085.

View in: PubMed
Sharma P, Shenoy A, Shroff H, Kwong A, Lim N, Pillai A, Devuni D, Haque LY, Balliet W, Serper M. Management of alcohol-associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities. Liver Transpl. 2024 Aug 01; 30(8):848-861.

View in: PubMed
Kanneganti M, Byhoff E, Serper M, Olthoff KM, Bittermann T. Neighborhood-level social determinants of health measures independently predict receipt of living donor liver transplantation in the United States. Liver Transpl. 2024 Jun 01; 30(6):618-627.

View in: PubMed
Kling CE, Biggins SW, Bambha KM, Feld LD, Perkins JH, Reyes JD, Perkins JD. Association of Body Surface Area With Access to Deceased Donor Liver Transplant and Novel Allocation Policies. JAMA Surg. 2023 06 01; 158(6):610-616.

View in: PubMed
Vatsalya V, Feng W, Kong M, Hu H, Szabo G, McCullough A, Dasarathy S, Nagy LE, Radaeva S, Barton B, Mitchell M, McClain CJ. The Beneficial Effects of Lactobacillus GG Therapy on Liver and Drinking Assessments in Patients with Moderate Alcohol-Associated Hepatitis. Am J Gastroenterol. 2023 08 01; 118(8):1457-1460.

View in: PubMed
Hassanein T, McClain CJ, Vatsalya V, Stein LL, Flamm SL, Martin P, Cave MC, Mitchell M, Barton B, Nagy L, Szabo G, McCullough A, Dasarathy S, Shah J, Blevins C, Scott D, Krebs W, Brown JE, Lin W. Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated Hepatitis. Am J Gastroenterol. 2024 01 01; 119(1):107-115.

View in: PubMed
Fundora Y, Hessheimer AJ, Del Prete L, Maroni L, Lanari J, Barrios O, Clarysse M, Gastaca M, Barrera G?mez M, Bonadona A, Janek J, Bosc? A, ?lamo Mart?nez JM, Zozaya G, L?pez Garnica D, Magistri P, Le?n F, Magini G, Patrono D, Nicovsk? J, Hakeem AR, Nadalin S, McCormack L, Palacios P, Zieniewicz K, Blanco G, Nu?o J, P?rez Saborido B, Echeverri J, Bynon JS, Martins PN, L?pez L?pez V, Dayangac M, Lodge JPA, Romagnoli R, Toso C, Santoyo J, Di Benedetto F, G?mez-Gavara C, Rotellar F, G?mez-Bravo M?, L?pez And?jar R, Girard E, Valdivieso A, Pirenne J, Llad? L, Germani G, Cescon M, Hashimoto K, Quintini C, Cillo U, Polak WG, Fondevila C. Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosis. J Hepatol. 2023 04; 78(4):794-804.

View in: PubMed
Szabo G, Mitchell M, McClain CJ, Dasarathy S, Barton B, McCullough AJ, Nagy LE, Kroll-Desrosiers A, Tornai D, Min HA, Radaeva S, Holbein MEB, Casey L, Cuthbert J. IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis. Hepatology. 2022 10; 76(4):1058-1068.

View in: PubMed
Sakai T, Ko JS, Crouch CE, Kumar S, Choi GS, Hackl F, Han DH, Kaufman M, Kim SH, Luzzi C, McCluskey S, Shin WJ, Sirianni J, Song KW, Sullivan C, Hendrickse A. Perioperative management of living donor liver transplantation: Part 2 - Donors. Clin Transplant. 2022 06; 36(6):e14690.

View in: PubMed
Hu K, Perez-Matos MC, Argemi J, Vilar-Gomez E, Shalaurova I, Bullitt E, Landeen L, Sugahara G, Deng H, Mathur K, Tran S, Cai H, He H, Yalcin Y, Vieira Barbosa J, Ventura-Cots M, Marx K, Gad AP, Niezen S, Izunza Barba S, Ang LH, Popov YV, Fricker Z, Lai M, Curry M, Afdhal N, Szabo G, Mukamal KJ, Sanyal AJ, Otvos JD, Malik R, Saito T, Connelly MA, Chalasani NP, Bataller R, Jiang ZG. Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol-associated hepatitis. Hepatology. 2022 04; 75(4):968-982.

View in: PubMed

People

Explore

Similar Concepts

Top Journals